101 – 110 of 781
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
- Contribution to journal › Article
-
Mark
Memories of Bob Sim-Genius Complementologist and Cheerful Travel Companion
- Contribution to journal › Debate/Note/Editorial
-
Mark
Chemokines modulate glycan binding and the immunoregulatory activity of galectins
- Contribution to journal › Article
-
Mark
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients
- Contribution to journal › Article
-
Mark
Active bacterial modification of the host environment through RNA polymerase II inhibition
- Contribution to journal › Article
-
Mark
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
- Contribution to journal › Article
-
Mark
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex
- Contribution to journal › Article
-
Mark
Entropy–Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3C
- Contribution to journal › Article
-
Mark
Synthesis and Biological Studies of O3-Aryl Galactosides as Galectin Inhibitors
- Contribution to journal › Article
